Risk factors associated with the development of Post COVID-19
DOI:
https://doi.org/10.56294/saludcyt2022221Keywords:
Failure, COVID-19, Post COVID-19, Cardiovascular Diseases, Cardiovascular Risk FactorsAbstract
Introduction: risk factors were one of the main problems associated with cardiovascular complications in patients post SARS CoV-2 infection. According to several studies, the main risk factors associated with the development of heart failure were hypertension and diabetes, associated with alterations in the Renin-Angiotensin-Aldosterone System and the ACE-2 receptor, as well as structural and functional alterations at the cardiac level.
Aim: to describe the risk factors associated with the development of heart failure after SARS CoV-2 infection.
Methods: narrative literature review using a systematic search through SciELO, ScienceDirect and PubMed databases.
Results: 14 articles were found and analyzed of which 7 articles explained and detailed the main risk factors while the other 7 articles described the pathogenic mechanisms associated with the development of post-infection heart failure.
Conclusions: the main risk factors associated with the development of heart failure are arterial hypertension, as well as diabetes mellitus, in addition to this thanks to the collection of information it was also evidenced that these factors are related to an increase in the mortality rate and deterioration in the quality of life of the patient
References
1. Krishnan A, Hamilton JP, Alqahtani SA, A Woreta T. A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med 2021;16:815-30. https://doi.org/10.1007/s11739-020-02616-5.
2. OPS. Informes de situación de la COVID-19. Organización Panamericana de la Salud 2022. https://www.paho.org/es/informes-situacion-covid-19.
3. Águila-Gordo D, Martínez-del Rio J, Negreira-Caamaño M, Mateo Gómez C, Soto Pérez M, Piqueras-Flores J. Enfermedad cardiovascular tras infección por SARS-CoV-2 en pacientes ancianos. Resultados del seguimiento anual de una cohorte de supervivientes. Rev Esp Geriatr Gerontol 2022;57:100-4. https://doi.org/10.1016/j.regg.2021.10.003.
4. Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. https://doi.org/10.1016/j.tem.2020.10.001.
5. Nelson C, Cancio R, Rivas-Estany E. Factores de riesgo cardiovasculares, diabetes y COVID-19. Cardiovascular risk factors, diabetes and COVID-19. 2021;27:e1100.
6. Bazurto GS, Castro MH, Núñez DS, Cedeño IB. Análisis de las complicaciones post-COVID-19 en pacientes con Enfermedades crónicas no trasmisibles. Revista Científica Higía de la Salud 2020;3. https://doi.org/10.37117/higia.v1i3.467.
7. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology 2020;5:811-8. https://doi.org/10.1001/jamacardio.2020.1017.
8. Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, et al. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation. Chemico-Biological Interactions 2022;351:109738. https://doi.org/10.1016/j.cbi.2021.109738.
9. Sena TC de S, Romão VS, Rocha RM, Ibieta GS, Silva ALF da, Feitosa IB. Cardiopatias crônicas e o Covid-19: virulência, patogenia e interação medicamentosa / Chronic cardiopathies and Covid-19: virulence, pathogeny and drug interaction. Brazilian Journal of Development 2022;8:21749-62. https://doi.org/10.34117/bjdv8n3-396.
10. Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021:cvab298. https://doi.org/10.1093/cvr/cvab298.
11. Comite Coodenador da directriz de ICC Y ICA. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol 2018;111:436-539. https://doi.org/10.5935/abc.20180190.
12. Liu Y, Wu S, Qin M, Jiang W, Liu X. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data. Journal of the American Heart Association 2020;9:e016812. https://doi.org/10.1161/JAHA.120.016812.
13. Navarrete-Mejía PJ, Lizaraso-Soto FA, Velasco-Guerrero JC, Loro-Chero LM, Navarrete-Mejía PJ, Lizaraso-Soto FA, et al. Diabetes mellitus e hipertensión arterial como factor de riesgo de mortalidad en pacientes con Covid-19. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 2020;13:361-5. https://doi.org/10.35434/rcmhnaaa.2020.134.766.
14. Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020:1-2. https://doi.org/10.1038/s41569-020-0360-5.
15. Moreno-Martínez FL, Moreno-López FL, Oroz Moreno R, Moreno-Martínez FL, Moreno-López FL, Oroz Moreno R. Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). CorSalud 2020;12:3-17.
16. Hierrezuelo Rojas N, Durruty Medina LE, Hernández Magdariaga A, García Gonzales E, Castellanos Hardy T, Hierrezuelo Rojas N, et al. Factores de riesgo cardiovascular asociados a la mortalidad de adultos mayores con COVID-19. MEDISAN 2022; 26(3):e4083.
17. Carriel J, Muñoz-Jaramillo R, Bolaños-Ladinez O, Heredia-Villacreses F, Menéndez-Sanchón J, Martin-Delgado J. CURB-65 como predictor de mortalidad a 30 días en pacientes hospitalizados con COVID-19 en Ecuador: estudio COVID-EC. Revista Clínica Española 2022;222:37-41. https://doi.org/10.1016/j.rce.2020.10.001.
18. Yupari-Azabache I, Bardales-Aguirre L, Rodriguez-Azabache J, Barros-Sevillano JS, Rodríguez-Diaz Á, Yupari-Azabache I, et al. Factores de riesgo de mortalidad por COVID-19 en pacientes hospitalizados: Un modelo de regresión logística. Revista de la Facultad de Medicina Humana 2021;21:19-27. https://doi.org/10.25176/rfmh.v21i1.3264.
19. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020;180:1345-55. https://doi.org/10.1001/jamainternmed.2020.3539.
20. Davis GK, Adlan A, Majewski J, Ibrahim B. SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know. Clin Med (Lond) 2020;20:262-5. https://doi.org/10.7861/clinmed.2020-0158.
21. Alfonso Mnocloa Bryce, Bryce M, Baracco A. COVID-19 desde una perspectiva cardiovascular. Archivos de Cardiología de México 2021;91(Supl2):86-94. https://doi.org/10.24875/ACM.20000304
Published
Issue
Section
License
Copyright (c) 2022 Kelly Paola Gómez Guapizaca , María Daniela Carpio Toro , Jessica Alexandra Estrada Morocho , Glenda Iris Montenegro Ortiz (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
